Aldine is pleased to announce its investment in R3 Wound Care and Hyperbarics (“R3”). R3 is a leading provider of high quality, outpatient wound care clinics and hyperbaric oxygen therapy (“HBOT”) centers. R3 specializes in treating diabetic ulcers, arterial insufficiency wounds, radiation wounds, and non-diabetic surgical wounds. The company operates three locations in the Dallas/Fort Worth, TX metropolitan area, as well a facility in the San Antonio region.
Aldine provided a subordinated note and equity investment alongside 3 Rivers Capital.